Jeffrey Fryer
No más puestos en curso
Historial de carrera de Jeffrey Fryer
Antiguos cargos conocidos de Jeffrey Fryer.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| RALLYBIO CORPORATION | Director Financiero/CFO | 01/01/2018 | 01/02/2023 |
| Fundador | 01/01/2018 | 01/02/2023 | |
| Treasurer | 01/01/2018 | 01/02/2023 | |
| ALEXION PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 01/04/2008 | 01/04/2017 |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Fundador | 01/01/2018 | - |
Formación de Jeffrey Fryer.
| University of Hartford | Graduate Degree |
| Bryant University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Founder | 2 |
| Director of Finance/CFO | 1 |
| Treasurer | 1 |
Sectorial
| Consumer Services | 3 |
| Health Technology | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| RALLYBIO CORPORATION | Health Technology |
| Empresas privadas | 2 |
|---|---|
Rallybio LLC
Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Rallybio LLC operates as a development-stage biotechnology company. The firm develops transformative therapies for patients. It focuses on bringing life-transforming medicines to patients with devastating and rare disorder. The company was founded by Martin Mackay, Stephen Uden and Jeffrey Fryer in 2018 and is headquartered in Farmington, CT. | Commercial Services |
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Jeffrey Fryer
- Experiencia
